http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Mesoblast Presents Commercial Plans at 2020 Biotech Showcase in San Francisco
-
Mesoblast (MESO) Submits Clinical Efficacy And Safety Data To FDA In Rolling Biologics License Application For Remestemcel-L
-
Mesoblast Submits Clinical Efficacy And Safety Data To FDA In Rolling Biologics License Application For Remestemcel-L
-
Data Monitoring Committee Completes Final Scheduled Review of Mesoblast’s Phase 3 Trial of Revascor in Advanced Chronic Heart Failure
-
Mesoblast’s Phase 3 Trial of Revascor in Advanced Chronic Heart Failure Surpasses the Number of Primary Endpoint Events for Trial Completion
-
Mesoblast Finanical Results for the Quarter Ended September 30, 2019
-
Mesoblast to Host Analyst Call on Financial Results for First Quarter Ended September 30, 2019
-
Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
-
Mesoblast Completes Successful Institutional Capital Raising of A$75 Million
